Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
November 14, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 14, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) and its subsidiary, Cannabis Biosciences, Inc., received a strong validation for their move into medical...
Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract
October 30, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc. Involved in Numerous Clinical Trials as Company Prepares Products for Market
October 03, 2013 09:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has several clinical trials already underway, and a host of others scheduled to commence in the company...
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
October 02, 2013 08:45 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnology, Inc. Announces New Extract in Its Ongoing Fight Against Malaria
October 01, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 1, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Buy Rating and New Report Issued for Plandai Biotechnology, Inc.
September 23, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 23, 2013) - Stock Market Media Group, a research and content development investor relations firm, has released its 3rd Quarter report and issued a Speculative Buy...
Plandai Biotechnology, Inc. Announces Commencement of Clinical Trials Using Phytofare Topical Product
September 05, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 5, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc.'s Phytofare Could Address Growing Diabetes Numbers
September 04, 2013 13:53 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) is already hard at work in Africa to develop a treatment for malaria, and it may just have a product in its...
Plandai Biotechnology, Inc. Announces Completion of Production Facility, Installation of Equipment to Commence
September 04, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc. Is Taking On the Malaria Parasite and Winning
June 06, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jun 6, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) recently put one of the company's highly bioavailable products to work in a study to prove it can kill a...